ATLASKiniksa Pharmaceuticals International (KNSA) earnings date: expected January 23–29
Kiniksa Pharmaceuticals International (KNSA) has not announced its next earnings date yet. Based on its last 4 reports, ATLAS expects it around January 23–29. That is an estimate, not a confirmed date.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on KNSA
| Last price | $90.71 (-1.7%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.6% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Kiniksa Pharmaceuticals International stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Expected around January 23–29 (estimate). One email the day before, with ATLAS’s read on Kiniksa Pharmaceuticals International. You can switch it off at any time.
Alert me before KNSA reportsFree to start. Creating an account takes under a minute.
Notify me when Kiniksa Pharmaceuticals International reports
Track KNSA free Add Kiniksa Pharmaceuticals International to a free ATLAS watchlist and see its next report date in one place.
KNSA earnings at a glance
| Next report | Not announced · expected around January 23–29 (ATLAS estimate) |
|---|---|
| Last report | Oct 27, 2026 · Beat |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | +16.6% |
| Average move around a report | ±18.1% (last 5) |
| Sector | Healthcare · Drug Manufacturers - Specialty & Generic |
The expected window is an ATLAS estimate: it takes the typical gap between Kiniksa Pharmaceuticals International’s last 4 reports and adds it to the most recent one. Companies announce the real date a few weeks ahead, and ATLAS switches the page to the confirmed date as soon as it is published.
Kiniksa Pharmaceuticals International earnings history: last 5 reports
Kiniksa Pharmaceuticals International last reported on Oct 27, 2026: EPS of $0.56 against an estimate of $0.32 (+75.0% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Oct 27, 2026 | $0.32 | $0.56 | +75.0% | Beat | +30.4% |
| Jul 28, 2026 | $0.28 | $0.30 | +7.1% | Beat | +27.4% |
| Jul 15, 2026 | $3.14 | $2.81 | -10.5% | Miss | -1.4% |
| Apr 28, 2026 | $0.16 | $0.27 | +68.8% | Beat | +21.5% |
| Feb 24, 2026 | $0.40 | $0.17 | -57.5% | Miss | -9.8% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for KNSA
See the fair value, the probability range and the earnings history of Kiniksa Pharmaceuticals International on its ATLAS page.
Kiniksa Pharmaceuticals International (KNSA) stock analysisPlans from €3.99 a month.
Kiniksa Pharmaceuticals International earnings: frequently asked questions
When is Kiniksa Pharmaceuticals International (KNSA) next earnings date?
Kiniksa Pharmaceuticals International has not announced its next report. Its last 4 reports came Oct 27, 2026, Jul 28, 2026, Apr 28, 2026, Feb 24, 2026, so ATLAS estimates the next one around January 23–29. This is an estimate based on that pattern, not a confirmed date.
How often does KNSA beat earnings estimates?
Of its last 5 reports with a recorded result, Kiniksa Pharmaceuticals International beat the EPS estimate 3 times; the average surprise was +16.6%. Past results do not predict the next one.
How much does KNSA move around earnings?
Over its last 5 reports the stock moved an average of 18.1% (absolute, from the close before the report day to the close after it), and finished higher 3 of 5 times.
Did Kiniksa Pharmaceuticals International beat earnings estimates last quarter?
Kiniksa Pharmaceuticals International last reported on Oct 27, 2026: EPS of $0.56 against an estimate of $0.32 (+75.0% surprise), a beat.
How much does KNSA usually move in a day?
On a normal trading day the ATLAS model puts KNSA’s one-day range at about ±4.6%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Educational information, not investment advice. Disclaimer